Bilgay Izci-Balserak1, Grace W Pien. 1. Center for Sleep and Respiratory Neurobiology, University of Pennsylvania School of Medicine, 3624 Market Street, Philadelphia, PA 19104, USA.
Abstract
PURPOSE OF REVIEW: This article reviews current data on pathophysiologic mechanisms by which sleep-disordered breathing during pregnancy may cause harm, and explores biological pathways for associated adverse maternal and fetal outcomes, especially pregnancy-induced hypertension and gestational diabetes. RECENT FINDINGS: Accumulating data indicate that snoring and sleep apnea during pregnancy are likely to increase the risk for gestational hypertension and preeclampsia. Several new studies have observed that sleep-disordered breathing and short sleep duration also increase the risk of gestational diabetes, similar to observations in the general population. There are varying levels of emerging evidence for potential mechanisms, including oxidative stress, increased sympathetic activity and inflammation, adipokine levels and insulin resistance, linking sleep-disordered breathing events during pregnancy to adverse outcomes. SUMMARY: Sleep-disordered breathing and adverse maternal-fetal outcomes such as preeclampsia and gestational diabetes share a number of mechanistic pathways, and growing data in pregnant women indicate that snoring and sleep apnea increase the risk of these and other complications for both the mother and the fetus. Nevertheless, direct evidence of the pathophysiologic mechanisms by which sleep-disordered breathing during pregnancy exerts negative effects remains sparse.
PURPOSE OF REVIEW: This article reviews current data on pathophysiologic mechanisms by which sleep-disordered breathing during pregnancy may cause harm, and explores biological pathways for associated adverse maternal and fetal outcomes, especially pregnancy-induced hypertension and gestational diabetes. RECENT FINDINGS: Accumulating data indicate that snoring and sleep apnea during pregnancy are likely to increase the risk for gestational hypertension and preeclampsia. Several new studies have observed that sleep-disordered breathing and short sleep duration also increase the risk of gestational diabetes, similar to observations in the general population. There are varying levels of emerging evidence for potential mechanisms, including oxidative stress, increased sympathetic activity and inflammation, adipokine levels and insulin resistance, linking sleep-disordered breathing events during pregnancy to adverse outcomes. SUMMARY:Sleep-disordered breathing and adverse maternal-fetal outcomes such as preeclampsia and gestational diabetes share a number of mechanistic pathways, and growing data in pregnant women indicate that snoring and sleep apnea increase the risk of these and other complications for both the mother and the fetus. Nevertheless, direct evidence of the pathophysiologic mechanisms by which sleep-disordered breathing during pregnancy exerts negative effects remains sparse.
Authors: Yüksel Peker; Jan Hedner; Jeanette Norum; Holger Kraiczi; Jan Carlson Journal: Am J Respir Crit Care Med Date: 2002-07-15 Impact factor: 21.405
Authors: Giovanna E Carpagnano; Sergei A Kharitonov; Onofrio Resta; Maria P Foschino-Barbaro; Enzo Gramiccioni; Peter J Barnes Journal: Chest Date: 2002-10 Impact factor: 9.410
Authors: Sharon J Herring; Emily Oken; Sheryl L Rifas-Shiman; Janet W Rich-Edwards; Alison M Stuebe; Ken P Kleinman; Matthew W Gillman Journal: Am J Obstet Gynecol Date: 2009-04-15 Impact factor: 8.661
Authors: Bilgay Izci Balserak; Nicholas Jackson; Sarah A Ratcliffe; Allan I Pack; Grace W Pien Journal: Sleep Breath Date: 2013-01-25 Impact factor: 2.816
Authors: Sirimon Reutrakul; Nausheen Zaidi; Kristen Wroblewski; Helen H Kay; Mahmoud Ismail; David A Ehrmann; Eve Van Cauter Journal: J Clin Endocrinol Metab Date: 2013-08-21 Impact factor: 5.958